Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
McKesson
Johnson and Johnson
Moodys
Colorcon

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

TEMOZOLOMIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Temozolomide, and when can generic versions of Temozolomide launch?

Temozolomide is a drug marketed by Accord Hlthcare, Amerigen Pharms Ltd, Amneal Pharms, Anda Repository, Apotex Inc, Barr, Chemi Spa, Deva Holding As, Idt Australia Ltd, Lannett Co Inc, Mylan, Sun Pharm, Watson Labs Teva, and Zydus Pharms. and is included in fourteen NDAs.

The generic ingredient in TEMOZOLOMIDE is temozolomide. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the temozolomide profile page.

Drug patent expirations by year for TEMOZOLOMIDE
Drug Prices for TEMOZOLOMIDE

See drug prices for TEMOZOLOMIDE

Recent Clinical Trials for TEMOZOLOMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ningbo Yinzhou People's HospitalPhase 1/Phase 2
BoYuan RunSheng Pharma (Hangzhou) Co., Ltd.Phase 1/Phase 2
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 1/Phase 2

See all TEMOZOLOMIDE clinical trials

Recent Litigation for TEMOZOLOMIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
CANCER RESEARCH TECHNOLOGY LIMITED v. SUN PHARMA GLOBAL FZE2010-09-15
Cancer Research Technology Limited v. Barr Laboratories Inc.2007-07-20

See all TEMOZOLOMIDE litigation

Pharmacology for TEMOZOLOMIDE
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Synonyms for TEMOZOLOMIDE
{Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,} 3, 4-dihydro-3-methyl-4-oxo-
199366-EP2275425A1
3-methyl-4-oxidanylidene-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide
3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide (Temozolomide)
3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide(Temozolomide)
3-Methyl-4-oxo-3,4-dihydroimidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide
3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide
3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide
3-METHYL-4-OXO-8-IMIDAZOLO[5,1-D][1,2,3,5]TETRAZINECARBOXAMIDE
3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-Methyl-8-aminocarbonyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one
3-methyl-8-carbamoyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide
3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide
4CA-1225
622T931
8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one
8-CARBAMOYL-3-METHYLIMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE
85622-93-1
A841386
AB0007590
AB00639915_10
AB00639915_11
AB00639915-06
AB00639915-08
AB00639915-09
AC-758
AC1L1K9B
AJ-26318
AK-72945
AKOS005557098
ALBB-021358
AM20110227
AN-5907
ANW-43023
AOB1657
BC206085
BCP03692
BCP0726000154
BDBM50034562
BIDD:GT0204
BPEGJWRSRHCHSN-UHFFFAOYSA-N
BR-72945
BRD-K32107296-001-04-5
BRN 5547136
C6H6N6O2
CAS-85622-93-1
CCG-100870
CCRG 81045
CCRG-81045
CCRIS 8996
CHEBI:72564
CHEMBL810
CJ-23657
CPD000466338
CS-0943
CT0139
CTK8B3724
D06067
DB00853
DL-190
DSSTox_CID_23714
DSSTox_GSID_43714
DSSTox_RID_80068
DTXSID5043714
FT-0630936
GTPL7301
HMS2051O12
HMS2090B08
HMS2232N13
HMS3264I14
HMS3269P05
HMS3372K13
HMS3393O12
HMS3654N05
HMS3713H16
HY-17364
I06-0149
I14-1943
Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-
Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-
Imidazo[5,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-
KB-80840
KS-00000XGV
KS-1216
LS-80558
M & B 39831
M-2350
M-39831
M&B 39831
M&B-39831
MB 39831
MCULE-9414994158
Methazolastone
MFCD00866492
MLS000759447
MLS001424028
MLS002701861
MolPort-003-850-406
NC00120
NCGC00167429-01
NCGC00167429-02
NCGC00167429-04
NCGC00167429-05
NCI60_003316
NSC 362856
NSC-362856
NSC-759883
NSC362856
NSC759883
Pharmakon1600-01502289
PubChem17413
Q-201786
s1237
SAM001246636
SC-17333
Sch 52365
Sch-52365
SCHEMBL3739
SMR000466338
SR-01000759347
SR-01000759347-4
SR-01000759347-5
STK623541
SW197500-4
Temodal
Temodal (TN)
Temodar
Temodar (TN)
Temodar (TN) (Schering)
Temozolamide
Temozolodida
Temozolodida [Spanish]
Temozolomid
temozolomida
Temozolomide (JAN/USAN/INN)
Temozolomide [INN:BAN]
Temozolomide [USAN:INN:BAN]
Temozolomide, >=98% (HPLC)
Temozolomide, Pharmaceutical Secondary Standard; Certified Reference Material
Temozolomide, United States Pharmacopeia (USP) Reference Standard
Temozolomide, VETRANAL(TM), analytical standard
Temozolomidum
Temozolomidum [Latin]
TL8005593
TMZ; NSC 362856; SCH 52365; CCRG 81045
Tox21_112433
Tox21_112433_1
UNII-YF1K15M17Y
YF1K15M17Y
Z1551429743
ZINC1482184
ZLA0002
zlchem 2
Paragraph IV (Patent) Challenges for TEMOZOLOMIDE
Tradename Dosage Ingredient NDA Submissiondate
TEMODAR CAPSULE;ORAL temozolomide 021029 2008-03-24
TEMODAR CAPSULE;ORAL temozolomide 021029 2007-03-20

US Patents and Regulatory Information for TEMOZOLOMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm TEMOZOLOMIDE temozolomide CAPSULE;ORAL 201742-006 Feb 12, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Chemi Spa TEMOZOLOMIDE temozolomide CAPSULE;ORAL 204639-005 Nov 23, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Barr TEMOZOLOMIDE temozolomide CAPSULE;ORAL 078879-002 Mar 1, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Mallinckrodt
Baxter
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.